Monday, October 7, 2013

Galectin-3 Strong Prognostic Marker in Patients with Pulmonary Hypertension

Patients with pulmonary hypertension and elevated galectin-3 were more likely to have a higher mortality rate at 4 years compared with patients with lower levels of the biomarker, according to data presented at the Annual Scientific Meeting of the Heart Failure Society of America.

Read article

No comments: